Can I take VRIEMPA L 25/5 TABLET with other diabetes medicines?

It may be used with other medicines, but only under strict medical supervision to avoid hypoglycemia.

Does VRIEMPA L 25/5 TABLET cause weight loss?

Many patients experience modest weight loss due to the excretion of glucose in the urine.

What should I do if I get a genital infection?

Maintain good hygiene and contact your doctor immediately, as this is a known side effect of SGLT2 inhibitors.

VRIEMPA L 25/5 TABLET

Generic Salt Composition: Empagliflozin 25mg + Linagliptin 5mg

Price: ₹70 MRP: ₹168

Save up to 58% compared to branded medicines.

Top Brand Substitutes & Equivalents

Jardiance Duo, Trajenta Duo, Empaglin, Linaglip-E, Empa-L, Glycimet-L, Empa-Lina, Linaglip-M, Empa-Duo, Jardimet, Empa-Lin, Empagliflozin Sun Pharma, Sun Pharma Empagliflozin, Empagliflozin Cipla, Cipla Empagliflozin, Empagliflozin Dr Reddys, Dr Reddys Empagliflozin, Empagliflozin Lupin, Lupin Empagliflozin, Empagliflozin Torrent, Torrent Empagliflozin, Empagliflozin Alkem, Alkem Empagliflozin, Empagliflozin Mankind, Mankind Empagliflozin, Empagliflozin Zydus, Zydus Empagliflozin, Empagliflozin Intas, Intas Empagliflozin, Empagliflozin Glenmark

Product Overview & Uses

VRIEMPA L 25/5 TABLET is a potent oral antidiabetic medication designed for the comprehensive management of Type 2 Diabetes Mellitus. Classified within the Diabetes Care category, this medication combines Empagliflozin (25mg) and Linagliptin (5mg). Empagliflozin works by inhibiting the sodium-glucose co-transporter 2 (SGLT2) in the kidneys, which prevents the reabsorption of glucose and promotes its elimination via urine. Simultaneously, Linagliptin acts as a DPP-4 inhibitor, increasing the levels of incretin hormones that stimulate insulin release and decrease glucagon production. The dual-action mechanism of VRIEMPA L 25/5 TABLET makes it an effective choice for patients who require more than monotherapy to achieve their glycemic targets. Beyond blood sugar control, this combination is often favored for its weight-neutral or weight-loss benefits and its low risk of hypoglycemia when used as directed. Patients prescribed VRIEMPA L 25/5 TABLET should maintain regular monitoring of blood glucose levels and adhere to lifestyle modifications, including diet and exercise, to maximize the therapeutic outcomes of this Diabetes Care treatment.